{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:36:42Z","timestamp":1791333402350,"version":"4.3.1"},"reference-count":154,"publisher":"Elsevier","isbn-type":[{"value":"9780128177303","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.irn.2019.10.010","type":"book-chapter","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T18:43:52Z","timestamp":1574361832000},"page":"377-418","source":"Crossref","is-referenced-by-count":31,"title":["Secondary parkinsonism due to drugs, vascular lesions, tumors, trauma, and other insults"],"prefix":"10.1016","member":"78","reference":[{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870040407","article-title":"Parkinsonism secondary to bilateral striatal fungal abscesses","volume":"4","author":"Adler","year":"1989","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.12890\/2019_001055","article-title":"Secondary parkinsonism due to a large anterior cranial fossa meningioma","volume":"6","author":"Al-Janabi","year":"2019","journal-title":"European Journal of Case Reports in Internal Medicine"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.010_bib3","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1080\/00207450903139648","article-title":"Cavernous hemangioma: A rare cause for secondary parkinsonism: A case report","volume":"119","author":"Alp","year":"2009","journal-title":"International Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1081\/CLT-120018273","article-title":"Transient and reversible parkinsonism after acute organophosphate poisoning","volume":"41","author":"Arima","year":"2003","journal-title":"Journal of Toxicology - Clinical Toxicology"},{"key":"10.1016\/bs.irn.2019.10.010_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.1961.03040120016004","article-title":"A survey of drug-induced extrapyramidal reactions","volume":"175","author":"Ayd","year":"1961","journal-title":"Journal of the American Medical Association"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.010_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s004150070070","article-title":"Assessment of gait in subcortical vascular encephalopathy by computerized analysis: A cross-sectional and longitudinal study","volume":"247","author":"B\u00e4zner","year":"2000","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/jnnp-2012-302618","article-title":"Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease","volume":"84","author":"Ben\u00edtez-Rivero","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/mds.10362","article-title":"Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain","volume":"18","author":"Benito-Le\u00f3n","year":"2003","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejim.2007.10.003","article-title":"Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism","volume":"19","author":"Bersano","year":"2008","journal-title":"European Journal of Internal Medicine"},{"issue":"Pt 4","key":"10.1016\/bs.irn.2019.10.010_bib10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioural and motor consequences of focal lesions of the basal ganglia in man","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain: A Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00367389","article-title":"Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women","volume":"227","author":"Bjerkenstedt","year":"1979","journal-title":"Archiv Fur Psychiatrie Und Nervenkrankheiten"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.010_bib12","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/mds.23828","article-title":"Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France","volume":"26","author":"Bondon-Guitton","year":"2011","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib13","first-page":"124","article-title":"A Parkinson-like syndrome as side effect of chemotherapy with vincristine and adriamycin in a child with acute leukaemia","volume":"31","author":"Boranic","year":"1979","journal-title":"Biomedicine\/[publiee Pour L'A.a.I.C.I.G.]"},{"issue":"18","key":"10.1016\/bs.irn.2019.10.010_bib14","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJM199910283411815","article-title":"More about parkinsonism after taking ecstasy","volume":"341","author":"Borg","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.010_bib15","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1007\/s00415-010-5631-3","article-title":"The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism","volume":"257","author":"Bovi","year":"2010","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.010_bib16","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.52.6.1214","article-title":"Incidence and distribution of parkinsonism in Olmsted county, Minnesota, 1976\u20131990","volume":"52","author":"Bower","year":"1999","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/mds.870100528","article-title":"Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma","volume":"10","author":"Bower","year":"1995","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.010_bib18","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/JOM.0b013e318233775d","article-title":"Systematic review of parkinsonian syndromes in short- and long-term survivors of paraquat poisoning","volume":"53","author":"Brent","year":"2011","journal-title":"Journal of Occupational and Environmental Medicine"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.010_bib19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.parkreldis.2014.05.011","article-title":"Differentiating drug-induced parkinsonism from Parkinson's disease: An update on non-motor symptoms and investigations","volume":"20","author":"Brigo","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.010_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/ene.12444","article-title":"12\u00b3IFP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: A meta-analysis","volume":"21","author":"Brigo","year":"2014","journal-title":"European Journal of Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/mds.20789","article-title":"Parkinsonism associated with basal ganglia cryptococcal abscesses in an immunocompetent patient","volume":"21","author":"Camargos","year":"2006","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1016\/bs.irn.2019.10.010_bib23","first-page":"1","article-title":"Management of chronic traumatic encephalopathy","author":"Cantu","year":"2019","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.010_bib24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.parkreldis.2014.04.013","article-title":"Age-, and gender-specific incidence of vascular parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: The PINE study","volume":"20","author":"Caslake","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000064954","article-title":"Parkinsonism after carbon monoxide poisoning","volume":"48","author":"Choi","year":"2002","journal-title":"European Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3340\/jkns.2012.51.3.144","article-title":"Astrocytoma in the third ventricle and hypothalamus presenting with parkinsonism","volume":"51","author":"Choi","year":"2012","journal-title":"Journal of Korean Neurosurgical Society"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004714-198602000-00005","article-title":"A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation","volume":"6","author":"Chouinard","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1531-8257(199903)14:2<364::AID-MDS1028>3.0.CO;2-I","article-title":"Brain stem cystic astrocytoma presenting with \"pure\" parkinsonism","volume":"14","author":"Cicarelli","year":"1999","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/106002800303700207","article-title":"Pseudo-Parkinson disease secondary to ritonavir-buspirone interaction","volume":"37","author":"Clay","year":"2003","journal-title":"The Annals of Pharmacotherapy"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/52.1.23","article-title":"Arteriosclerotic parkinsonism","volume":"52","author":"Critchley","year":"1929","journal-title":"Brain: A Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib31","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/1531-8257(199905)14:3<520::AID-MDS1026>3.0.CO;2-V","article-title":"Parkinsonism from methanol poisoning: Benefit from treatment with anti-Parkinson drugs","volume":"14","author":"Davis","year":"1999","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jnnp.72.1.77","article-title":"Gait apraxia after bilateral supplementary motor area lesion","volume":"72","author":"Della Sala","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000468454","article-title":"Clinical evaluation of bromperidol versus haloperidol in psychotic patients","volume":"15","author":"Denijs","year":"1980","journal-title":"International Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00259-009-1289-4","article-title":"Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease","volume":"37","author":"Diaz-Corrales","year":"2010","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/bs.irn.2019.10.010_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuro.2016.01.004","article-title":"MRI pallidal signal in children exposed to manganese in drinking water","volume":"53","author":"Dion","year":"2016","journal-title":"Neurotoxicology"},{"issue":"Pt 7","key":"10.1016\/bs.irn.2019.10.010_bib36","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/brain\/122.7.1349","article-title":"Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy","volume":"122","author":"Ebersbach","year":"1999","journal-title":"Brain: A Journal of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00000542-199507000-00036","article-title":"Parkinsonian signs may be related to bupivacaine excess","volume":"83","author":"Elias","year":"1995","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.010_bib38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/mds.26209","article-title":"Parkinsonism following neuroleptic exposure: A double-hit hypothesis?","volume":"30","author":"Erro","year":"2015","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ncpneuro0688","article-title":"Lower-body parkinsonism: Reconsidering the threshold for external lumbar drainage","volume":"4","author":"Espay","year":"2008","journal-title":"Nature Clinical Practice Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.010_bib40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s40266-018-0590-y","article-title":"Current methods for the treatment and prevention of drug-induced parkinsonism and tardive dyskinesia in the elderly","volume":"35","author":"Estevez-Fraga","year":"2018","journal-title":"Drugs & Aging"},{"issue":"4\u20135","key":"10.1016\/bs.irn.2019.10.010_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0161-813X(02)00033-5","article-title":"Progressive parkinsonism in a young experimental physicist following long-term exposure to methanol","volume":"23","author":"Finkelstein","year":"2002","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/mds.870040306","article-title":"Lower body parkinsonism: Evidence for vascular etiology","volume":"4","author":"FitzGerald","year":"1989","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1016\/bs.irn.2019.10.010_bib43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.parkreldis.2018.03.030","article-title":"Descriptive epidemiology of parkinsonism in the canton of Geneva, Switzerland","volume":"54","author":"Fleury","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib44","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.10317","article-title":"Parkinsonism as a manifestation of multiple sclerosis","volume":"18","author":"Folgar","year":"2003","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.010_bib45","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/mds.25049","article-title":"Nigrostriatal pathway dysfunction in a methanol-induced delayed dystonia-parkinsonism","volume":"27","author":"Franquet","year":"2012","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.010_bib46","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/mds.27050","article-title":"Drug-induced parkinsonism","volume":"32","author":"Friedman","year":"2017","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1445-5994.1994.tb01479.x","article-title":"A reversible parkinsonian syndrome and hepatotoxcity following addition of carbamazepine to sodium valproate","volume":"24","author":"Froomes","year":"1994","journal-title":"Australian & New Zealand Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib155","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.410110313","article-title":"Biochemical findings in a case of parkinsonism secondary to brain tumor","volume":"11","author":"Garc\u00eda de Y\u2019ebenes","year":"1982","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp.34.1.20","article-title":"Transitory procaine-induced parkinsonism","volume":"34","author":"Gjerris","year":"1971","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.010_bib49","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/jnnp-2012-302828","article-title":"The clinical features of pathologically confirmed vascular parkinsonism","volume":"83","author":"Glass","year":"2012","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.1047","article-title":"Hemi-parkinsonism due to a midbrain arteriovenous malformation: Dopamine transporter imaging","volume":"16","author":"Goldstein","year":"2001","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/toxsci\/kfv099","article-title":"Manganese-induced parkinsonism is not idiopathic Parkinson's disease: Environmental and genetic evidence","volume":"146","author":"Guilarte","year":"2015","journal-title":"Toxicological Sciences: An Official Journal of the Society of Toxicology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/NRL.0b013e31816c43ea","article-title":"Hemiparkinsonism secondary to an infiltrative astrocytoma","volume":"14","author":"Ho","year":"2008","journal-title":"The Neurologist"},{"key":"10.1016\/bs.irn.2019.10.010_bib53","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1752-1947-4-218","article-title":"Parkinsonism secondary to metastatic lesions within the central nervous system: A case report","volume":"4","author":"Hortelano","year":"2010","journal-title":"Journal of Medical Case Reports"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib55","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0404.1988.tb03653.x","article-title":"Parkinsonism induced by pyridostigmine","volume":"78","author":"Iwasaki","year":"1988","journal-title":"Acta Neurologica Scandinavica"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.010_bib56","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/mds.25458","article-title":"Head injury and risk of Parkinson disease: A systematic review and meta-analysis","volume":"28","author":"Jafari","year":"2013","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib57","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/mds.21188","article-title":"Valproate-induced parkinsonism in epilepsy patients","volume":"22","author":"Jamora","year":"2007","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.010_bib58","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","article-title":"Viral parkinsonism","volume":"1792","author":"Jang","year":"2009","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib59","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00401-003-0676-3","article-title":"Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study","volume":"105","author":"Jellinger","year":"2003","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib60","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","article-title":"Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease","volume":"115","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathologica"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.010_bib61","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/070674370104600615","article-title":"Bupropion and drug-induced parkinsonism","volume":"46","author":"Jerome","year":"2001","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/1353-8020(96)00013-2","article-title":"Drug-induced parkinsonism in a movement disorders unit: A four-year survey","volume":"2","author":"Jim\u00e9nez-Jim\u00e9nez","year":"1996","journal-title":"Parkinsonism & Related Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.010_bib63","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archneur.59.10.1597","article-title":"A clinicopathological study of vascular progressive supranuclear palsy: A multi-infarct disorder presenting as progressive supranuclear palsy","volume":"59","author":"Josephs","year":"2002","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.010_bib64","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1136\/jnnp.2003.035287","article-title":"Olfactory function distinguishes vascular parkinsonism from Parkinson's disease","volume":"75","author":"Katzenschlager","year":"2004","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.010_bib65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1017\/S1092852916000444","article-title":"Once-monthly paliperidone palmitate compared with conventional and atypical daily oral antipsychotic treatment in patients with schizophrenia","volume":"21","author":"Kim","year":"2016","journal-title":"CNS Spectrums"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.15280\/jlm.2014.4.2.101","article-title":"Intracranial meningioma-induced parkinsonism","volume":"4","author":"Kim","year":"2014","journal-title":"Journal of Lifestyle Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib67","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.archger.2012.05.001","article-title":"Combined use of 12\u00b3I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced parkinsonism (DIP): A 2-year follow-up study","volume":"56","author":"Kim","year":"2013","journal-title":"Archives of Gerontology and Geriatrics"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuchi.2016.06.002","article-title":"Hemiparkinsonism secondary to sphenoid wing meningioma","volume":"62","author":"Kleib","year":"2016","journal-title":"Neurochirurgie"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006624.pub2","article-title":"Sertindole versus other atypical antipsychotics for schizophrenia","author":"Komossa","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.010_bib70","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneurol.2015.61","article-title":"Vascular parkinsonism--characteristics, pathogenesis and treatment","volume":"11","author":"Korczyn","year":"2015","journal-title":"Nature Reviews Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib71","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1111\/ejn.12628","article-title":"Methamphetamine self-administration results in persistent dopaminergic pathology: Implications for Parkinson's disease risk and reward-seeking","volume":"40","author":"Kousik","year":"2014","journal-title":"European Journal of Neuroscience"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.010_bib72","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/jnnp.55.12.1162","article-title":"Movement disorders in astrocytomas of the basal ganglia and the thalamus","volume":"55","author":"Krauss","year":"1992","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2019.10.010_bib73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF01404943","article-title":"Parkinsonism and rest tremor secondary to supratentorial tumours sparing the basal ganglia","volume":"133","author":"Krauss","year":"1995","journal-title":"Acta Neurochirurgica"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.010_bib74","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s00415-008-0993-5","article-title":"Neuroleptic-induced parkinsonism is associated with olfactory dysfunction","volume":"255","author":"Kr\u00fcger","year":"2008","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib75","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ana.410390326","article-title":"Cytosine arabinoside and amphotericin B-induced parkinsonism","volume":"39","author":"Kulkantrakorn","year":"1996","journal-title":"Annals of Neurology"},{"issue":"s1","key":"10.1016\/bs.irn.2019.10.010_bib76","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3233\/JPD-179006","article-title":"The MPTP story","volume":"7","author":"Langston","year":"2017","journal-title":"Journal of Parkinson's Disease"},{"issue":"4587","key":"10.1016\/bs.irn.2019.10.010_bib77","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib78","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jnnp.2005.073999","article-title":"Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism","volume":"77","author":"Lee","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"11","key":"10.1016\/bs.irn.2019.10.010_bib79","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1136\/jnnp.2007.121285","article-title":"Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism","volume":"78","author":"Lee","year":"2007","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14802\/jmd.16045","article-title":"Clinical features indicating nigrostriatal dopaminergic degeneration in drug-induced parkinsonism","volume":"10","author":"Lee","year":"2017","journal-title":"Journal of Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib81","article-title":"Benperidol for schizophrenia","author":"Leucht","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002832.pub3","article-title":"Perazine for schizophrenia","author":"Leucht","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib83","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/WNL.55.4.591","article-title":"Postanoxic parkinsonism: Clinical, radiologic, and pathologic correlation","volume":"55","author":"Li","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2019.10.010_bib84","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3389\/fneur.2019.00652","article-title":"Infectious etiologies of parkinsonism: Pathomechanisms and clinical implications","volume":"10","author":"Limphaibool","year":"2019","journal-title":"Frontiers in Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11598540-000000000-00000","article-title":"Drug-induced parkinsonism in the elderly: Incidence, management and prevention","volume":"29","author":"L\u00f3pez-Send\u00f3n","year":"2012","journal-title":"Drugs & Aging"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib86","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mds.870130313","article-title":"Cinnarizine-induced parkinsonism: Ten years later","volume":"13","author":"Mart\u00ed-Mass\u00f3","year":"1998","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-510X(99)00075-1","article-title":"Intracranial dural arteriovenous fistula (DAVF) presenting progressive dementia and parkinsonism","volume":"165","author":"Matsuda","year":"1999","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.010_bib88","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/01.wnl.0000250230.86581.ea","article-title":"Acute parkinsonism with corresponding lesions in the basal ganglia after heroin abuse","volume":"68","author":"M\u00e4tzler","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-015-1515-z","article-title":"The first NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy","volume":"131","author":"McKee","year":"2016","journal-title":"Acta Neuropathologica"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.010_bib90","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/NEN.0b013e3181a9d503","article-title":"Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury","volume":"68","author":"McKee","year":"2009","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"Pt 1","key":"10.1016\/bs.irn.2019.10.010_bib91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/aws307","article-title":"The spectrum of disease in chronic traumatic encephalopathy","volume":"136","author":"McKee","year":"2013","journal-title":"Brain: A Journal of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib92","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00004714-199508000-00008","article-title":"Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol","volume":"15","author":"McSwain","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib93","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.2017.8334","article-title":"Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football","volume":"318","author":"Mez","year":"2017","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/bs.irn.2019.10.010_bib94","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fneur.2017.00481","article-title":"Therapeutic interventions for vascular parkinsonism: A systematic review and meta-analysis","volume":"8","author":"Miguel-Puga","year":"2017","journal-title":"Frontiers in Neurology"},{"issue":"18","key":"10.1016\/bs.irn.2019.10.010_bib95","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJM199905063401817","article-title":"Parkinsonism after taking ecstasy","volume":"340","author":"Mintzer","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib96","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mdc3.12458","article-title":"Olfactory impairment predicts underlying dopaminergic deficit in presumed drug-induced parkinsonism","volume":"4","author":"Morley","year":"2017","journal-title":"Movement Disorders Clinical Practice"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib97","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JPD-130299","article-title":"Use of hyposmia and other non-motor symptoms to distinguish between drug-induced parkinsonism and Parkinson's disease","volume":"4","author":"Morley","year":"2014","journal-title":"Journal of Parkinson's Disease"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.010_bib98","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.parkreldis.2014.03.024","article-title":"Motor and non-motor features of Parkinson's disease that predict persistent drug-induced parkinsonism","volume":"20","author":"Morley","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2019.10.010_bib99","article-title":"Pimozide for schizophrenia or related psychoses","volume":"11","author":"Mothi","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10072-016-2771-y","article-title":"Not all drug-induced parkinsonism are the same: The effect of drug class on motor phenotype","volume":"38","author":"Munhoz","year":"2017","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib101","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.clineuro.2010.03.003","article-title":"The differential diagnoses of parkinsonism: Findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics","volume":"112","author":"Munhoz","year":"2010","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib102","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/mds.870090119","article-title":"Temporary symptom worsening caused by manidipine hydrochloride in two patients with Parkinson's disease","volume":"9","author":"Nakashima","year":"1994","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib103","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2013.10.025","article-title":"123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease","volume":"20","author":"Navarro-Otano","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib104","first-page":"423","article-title":"Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group","volume":"90","author":"Nordic Dyskinesia Study Group","year":"1986","journal-title":"Psychopharmacology"},{"issue":"21","key":"10.1016\/bs.irn.2019.10.010_bib105","doi-asserted-by":"crossref","first-page":"e6967","DOI":"10.1097\/MD.0000000000006967","article-title":"123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders","volume":"96","author":"Nuvoli","year":"2017","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/bs.irn.2019.10.010_bib106","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.parkreldis.2009.03.007","article-title":"Reversible parkinsonism with oxcarbazepine use","volume":"15","author":"Okuyucu","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib107","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mds.1270","article-title":"Vascular parkinsonism: Clinical correlates predicting motor improvement after lumbar puncture","volume":"17","author":"Ondo","year":"2002","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib108","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7861\/clinmedicine.16-4-371","article-title":"Imaging in Parkinson's disease","volume":"16","author":"Pagano","year":"2016","journal-title":"Clinical Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib109","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.parkreldis.2014.12.017","article-title":"Systematic review and meta-analysis of hydrocarbon exposure and the risk of Parkinson's disease","volume":"21","author":"Palin","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/bs.irn.2019.10.010_bib110","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-009752","article-title":"Extrapyramidal syndrome","volume":"2014","author":"Panda","year":"2014","journal-title":"BMJ Case Reports"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib111","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/NRL.0000000000000114","article-title":"Unilateral parkinsonism: Symptomatic of brain tuberculoma","volume":"22","author":"Pandey","year":"2017","journal-title":"The Neurologist"},{"key":"10.1016\/bs.irn.2019.10.010_bib112","series-title":"An essay on the shaking palsy","author":"Parkinson","year":"1817"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib113","first-page":"29","article-title":"Chloroquine induced parkinsonism","volume":"46","author":"Parmar","year":"2000","journal-title":"Journal of Postgraduate Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.010_bib114","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WNF.0b013e3181a9eb1b","article-title":"Pregabalin-induced parkinsonism: A case report","volume":"32","author":"Perez Lloret","year":"2009","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0090-3019(85)90161-2","article-title":"Parkinsonism as a manifestation of brain tumor","volume":"23","author":"Polyzoidis","year":"1985","journal-title":"Surgical Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib116","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1552-6569.2005.tb00299.x","article-title":"Carbon monoxide brain toxicity: Clinical, magnetic resonance imaging, magnetic resonance spectroscopy, and neuropsychological effects in 9 people","volume":"15","author":"Prockop","year":"2005","journal-title":"Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib117","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/WNL.0000000000003533","article-title":"Dose-dependent progression of parkinsonism in manganese-exposed welders","volume":"88","author":"Racette","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.010_bib118","first-page":"1398","article-title":"MR changes after acute cyanide intoxication","volume":"23","author":"Rachinger","year":"2002","journal-title":"AJNR. American Journal of Neuroradiology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib119","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.clpt.6100013","article-title":"Two cases of rapid onset Parkinson's syndrome following toxic ingestion of ethylene glycol and methanol","volume":"81","author":"Reddy","year":"2007","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/bs.irn.2019.10.010_bib120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2017.12.030","article-title":"An updated diagnostic approach to subtype definition of vascular parkinsonism - recommendations from an expert working group","volume":"49","author":"Rektor","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib121","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00000542-197505000-00034","article-title":"Persistent parkinsonism following neuroleptanalgesia","volume":"42","author":"Rivera","year":"1975","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib122","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.027","article-title":"Pure hemiparkinsonism secondary to contralateral lacunar stroke in the substantia nigra","volume":"25","author":"Robles","year":"2016","journal-title":"Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib123","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.39.1.142","article-title":"Cyanide-induced parkinsonism: Clinical, MRI, and 6-fluorodopa PET studies","volume":"39","author":"Rosenberg","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2019.10.010_bib124","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.lfs.2015.11.006","article-title":"Potential role of organochlorine pesticides in the pathogenesis of neurodevelopmental, neurodegenerative, and neurobehavioral disorders: A review","volume":"145","author":"Saeedi Saravi","year":"2016","journal-title":"Life Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00002826-198506000-00013","article-title":"Parkinsonism induced by captopril","volume":"8","author":"Sandyk","year":"1985","journal-title":"Clinical Neuropharmacology"},{"issue":"12","key":"10.1016\/bs.irn.2019.10.010_bib126","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/mds.21125","article-title":"Parkinsonism due to lamotrigine","volume":"21","author":"Santens","year":"2006","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib127","first-page":"48","article-title":"Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia","volume":"61","author":"Sarasombath","year":"2002","journal-title":"Hawaii Medical Journal"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib128","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/WNF.0000000000000278","article-title":"Trazodone and parkinsonism: The link strengthens","volume":"41","author":"Sarwar","year":"2018","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/mds.26839","article-title":"Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study","volume":"32","author":"Savica","year":"2017","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1352458510384306","article-title":"Rapidly progressive course of very late onset multiple sclerosis presenting with parkinsonism: Case report","volume":"17","author":"Schultheiss","year":"2011","journal-title":"Multiple Sclerosis"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/cn400189s","article-title":"Clozapine, a fast-off-D2 antipsychotic","volume":"5","author":"Seeman","year":"2014","journal-title":"ACS Chemical Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib132","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10072-014-1945-8","article-title":"Clinical features of drug-induced parkinsonism based on 18F FP-CIT positron emission tomography","volume":"36","author":"Shin","year":"2015","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib133","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.4081\/ni.2018.7877","article-title":"Clinical features of drug-induced parkinsonism","volume":"10","author":"Shiraiwa","year":"2018","journal-title":"Neurology International"},{"key":"10.1016\/bs.irn.2019.10.010_bib134","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/bs.irn.2015.02.002","article-title":"Methcathinone \"Kitchen chemistry\" and permanent neurological damage","volume":"120","author":"Sikk","year":"2015","journal-title":"International Review of Neurobiology"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/mpo.10111","article-title":"Secondary parkinsonism: An unusual late complication of craniospinal radiotherapy given to a 16-month child","volume":"40","author":"Skiming","year":"2003","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1016\/bs.irn.2019.10.010_bib136","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fneur.2019.00152","article-title":"Cardiac 123I-MIBG scintigraphy in neurodegenerative Parkinson syndromes: Performance and pitfalls in clinical practice","volume":"10","author":"Skowronek","year":"2019","journal-title":"Frontiers in Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2019.10.010_bib137","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archneur.57.8.1214","article-title":"The brain lesion responsible for parkinsonism after carbon monoxide poisoning","volume":"57","author":"Sohn","year":"2000","journal-title":"Archives of Neurology"},{"issue":"13","key":"10.1016\/bs.irn.2019.10.010_bib138","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.0b013e3182a55f7f","article-title":"Clinical presentation of chronic traumatic encephalopathy","volume":"81","author":"Stern","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib139","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0006-3223(85)90048-4","article-title":"Parkinsonism induced by high doses of diazepam","volume":"20","author":"Suranyi-Cadotte","year":"1985","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2019.10.010_bib140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0166-2236(89)90135-5","article-title":"The role of environmental toxins in the etiology of Parkinson's disease","volume":"12","author":"Tanner","year":"1989","journal-title":"Trends in Neurosciences"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mds.870020101","article-title":"Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease","volume":"2","author":"Thompson","year":"1987","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"13","key":"10.1016\/bs.irn.2019.10.010_bib142","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/mds.22098","article-title":"123IFP-CIT SPET imaging in drug-induced parkinsonism","volume":"23","author":"Tinazzi","year":"2008","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib143","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/jnnp.2009.177683","article-title":"Neurological picture. Secondary parkinsonism due to arachnoid cyst of the frontal lobe","volume":"81","author":"Tiple","year":"2010","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.010_bib144","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1034\/j.1600-0404.2002.01189.x","article-title":"White matter changes in normal pressure hydrocephalus and Binswanger disease: Specificity, predictive value and correlations to axonal degeneration and demyelination","volume":"105","author":"Tullberg","year":"2002","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/bs.irn.2019.10.010_bib145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.parkreldis.2018.06.030","article-title":"Parkinsonism in a population-based study of individuals aged 75+ years: The Piet\u00e0 study","volume":"56","author":"Vale","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2019.10.010_bib146","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1054\/jocn.2000.0895","article-title":"Pineal cavernous angioma presenting with parkinsonism","volume":"8","author":"Vhora","year":"2001","journal-title":"Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia"},{"issue":"9","key":"10.1016\/bs.irn.2019.10.010_bib147","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/mds.22908","article-title":"A historical analysis of the relationship between encephalitis lethargica and postencephalitic parkinsonism: A complex rather than a direct relationship","volume":"25","author":"Vilensky","year":"2010","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"7","key":"10.1016\/bs.irn.2019.10.010_bib148","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/mds.26263","article-title":"Vascular parkinsonism: Deconstructing a syndrome","volume":"30","author":"Vizcarra","year":"2015","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/bs.irn.2019.10.010_bib149","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.0b013e3182267bc4","article-title":"Slowly progressive Parkinson syndrome due to thalamic butterfly astrocytoma","volume":"77","author":"W\u00e4chter","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archneur.56.1.98","article-title":"Clinical correlates of vascular parkinsonism","volume":"56","author":"Winikates","year":"1999","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2019.10.010_bib151","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2018.04.037","article-title":"DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice","volume":"53","author":"Yomtoob","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2019.10.010_bib152","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nic.2009.08.006","article-title":"The role of imaging in the diagnosis of vascular parkinsonism","volume":"20","author":"Zijlmans","year":"2010","journal-title":"Neuroimaging Clinics of North America"},{"issue":"6","key":"10.1016\/bs.irn.2019.10.010_bib153","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"5","key":"10.1016\/bs.irn.2019.10.010_bib154","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mds.870110505","article-title":"Quantitative gait analysis in patients with vascular parkinsonism","volume":"11","author":"Zijlmans","year":"1996","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"}],"container-title":["International Review of Neurobiology","Parkinsonism Beyond Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774219300960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774219300960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:14:42Z","timestamp":1758748482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774219300960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128177303"],"references-count":154,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2019.10.010","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}